Medicinal Products

Besponsa

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Besponsa
Active Substance inotuzumab ozogamicin
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC26
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Back